The American Society of Clinical Oncology (ASCO) has been notified of a recent safety notice for the drug Jubbonti (denosumab-bbdz) under the Food and Drug Administration’s Risk Evaluation and ...

Decentralized clinical trial elements can be safely adopted as permanent fixtures without substantial reductions in data quality or increased risk to research participants, according to a new study in ...

The Association for Clinical Oncology (ASCO) is urging lawmakers to prioritize federal cancer research in Fiscal Year (FY) 2026 by providing the National Institutes of Health (NIH), National Cancer ...

Disclaimer This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information ...

The Association for Clinical Oncology (ASCO) is outlining key priorities for the next generation of biomedical innovation policy in response to “A Roadmap for 21st Century Cures,” a white paper ...

From May 30 to June 3 in Chicago, Illinois, and online, cancer researchers and clinicians from around the world will gather for the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

The 2026 cycle opens July 1, 2025. All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent ...